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 Case Report/Relato de Caso
Cutaneous cryptococcosis due to Cryptococcus gattii in a patient on chronic 
corticotherapy
Criptococose cutânea causada por Cryptococcus gattii em um paciente sob corticoterapia 
crônica
Fernando Bellissimo-Rodrigues1, Maysa Baciotti1, Maria Paula Zanatto1, Jaqueline Otero Silva2, Marilena dos 
Anjos Martins2 and Roberto Martinez3
RESUMO
Cryptococcus gattii é agente causador de uma micose endêmica que afeta 
principalmente os pulmões e o sistema nervoso central de pacientes 
imunocompetentes em regiões tropicais e subtropicais do globo.  Relato 
de caso. Um paciente de 66 anos, portador de doença pulmonar obstrutiva 
crônica, não infectado pelo vírus HIV, em corticoterapia sistêmica 
prolongada, desenvolveu extensa ulceração do antebraço esquerdo, associada 
a adenomegalia supraclavicular ipsilateral, em conseqüência à infecção por 
Cryptococcus gattii. O paciente foi tratado com fluconazol 400mg/dia durante 
8 meses, obtendo resolução completa da lesão. Este caso enfatiza que, ainda 
que raramente, C. gattii pode causar infecção cutâneo-linfática oportunista, 
em paciente imunocomprometido pelo uso sistêmico de corticosteróides 
vivendo na região sudeste do Brasil. 
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ABSTRACT
Cryptococcus gattii causes a form of endemic mycosis that most commonly 
affects the lungs and central nervous system of immunocompetent 
patients living in tropical and subtropical areas of the world. Case report. A 
66-year-old man who had chronic obstructive pulmonary disease without 
HIV infection and had been on systemic corticotherapy for several years 
developed extensive ulceration of the left forearm that was associated 
with ipsilateral supraclavicular adenomegaly, consequent to infection with 
Cryptococcus gattii. The patient was treated with fluconazole 400mg/day 
for eight months, which led to complete healing of the lesion. This case 
emphasizes that, although rare, C. gattii may cause opportunistic cutaneous-
lymphatic infection in patients living in the southeastern region of Brazil who 
are immunocompromised through chronic corticotherapy.
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INTRODUCTION
Cryptococcosis is a type of mycosis that most commonly affects 
the lungs and central nervous system (CNS). Two species are most 
frequently isolated from human infections: Cryptococcus neoformans 
and Cryptococcus gattii1.
While C. neoformans has worldwide distribution, can be found in 
soil and in excretions from many animals, and predominantly affects 
immunocompromised patients, C. gattii has been mostly isolated 
from decomposing wood in tropical or subtropical areas and appears 
to be more virulent, affecting immunocompetent patients more 
frequently1-3. Exposure to inhalation of both species is a well-known 
risk factor for developing cryptococcosis. 
CASE REPORT
Here, we present a case report on a 66-year-old man who came 
to our hospital with a painful ulcerated lesion in his left forearm 
that he had had for 35 days. He reported that, initially, a small 
erythematous papule had appeared in the forearm, which became an 
ulcer and gradually grew until reaching the entire dorsal surface of 
the forearm (Figure 1). He said that he did not have any history of 
local skin trauma, fever, respiratory symptoms, headache or any other 
symptoms. Before admission, his personal doctor had prescribed 
oral ciprofloxacin and clindamycin for a week but the patient had 
not noticed any improvement of the lesion.
FIgURE 1 - Skin lesion associated with Cryptococcus gattii infection on the left 
forearm of a patient who had been on chronic corticotherapy.
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DISCUSSION
His epidemiological history included tobacco and alcohol 
consumption for 25 years, but he had quit these habits 30 years ago. 
He was born and was still living in an urban area of the City of Ribeirão 
Preto, State of São Paulo, southeastern Brazil. He had worked as an auto 
mechanic and had been retired for the last six years.
After retirement, he started to go fishing every month on a river 
surrounded by subtropical forest near the City of Ribeirão Preto 
and, every morning, he fed hundreds of wild pigeons on a public 
square near his home. 
As a consequence of his history of tobacco consumption, he 
had developed chronic obstructive pulmonary disease (COPD), 
and had been using prednisone 20mg/day (0.3mg/kg/day) for the 
last 20 years.
On physical examination, besides the skin lesion described above, 
a left supraclavicular lymphatic node enlargement was detected 
by palpation, of around 3cm in diameter. The rest of the physical 
examination was unremarkable.
Since the clinical diagnosis was not obvious, we performed 
a biopsy on the skin lesion and sent the material for culturing of 
bacteria, mycobacteria and fungi, and also for histopathological 
analysis. The latter revealed chronic inflammation associated with 
yeast-like cells, through staining using the Gomori methenamine 
silver (GMS) method, which was suggestive of Cryptococcus sp. 
Culturing of the skin biopsy in Sabouraud dextrose agar medium 
revealed growth of Cryptococcus sp, which was ultimately identified 
as C. gattii by means of the phenoloxidase and canavanine-glycine-
bromothymol blue tests, which were both positive. Following this, 
a chest computed tomography scan was performed in order to 
detect any subclinical pulmonary involvement. The findings were 
consistent with COPD and showed no signs of pulmonary infection. 
Cerebrospinal fluid was not collected because of the absence of 
headache or any other signs of CNS involvement. Counter-immune 
electrophoresis for cryptococcosis antibodies was performed on the 
patient’s serum, with positive results down to the dilution of 1:2. Anti-
HIV ELISA showed negative results and serum glucose levels were 
normal. We did not detect any signs of any other organ involvement, 
or of any other immunosuppressive diseases.
After the diagnosis, prednisone was replaced by aerosolized 
formoterol plus budesonide and the patient was also treated with oral 
fluconazole 400mg/day. He was discharged two weeks after the onset 
of treatment, with a slight improvement of the lesion. As an outpatient, 
treatment with fluconazole 400mg/day was continued until the lesion 
had completely healed, which took eight months to occur. At the end 
of the treatment, the left supraclavicular lymphatic node was no longer 
detectable by palpation. The lesion scar led to inability to completely 
extend the forearm, as a small sequela. So far (two years after the end 
of treatment), no signs of recurrence have been detected.
Cutaneous cryptococcosis may occur as a consequence of 
hematogenic dissemination of yeasts, after inhalation exposure, 
or as a local disease, following skin injury, especially when caused 
by untreated wood1-8. In this case, infection apparently became 
established through inhalation of fungi, as suggested by the presence 
of the supraclavicular lymph node enlargement and the absence 
of skin injury history, but no signs of disseminated disease were 
detected.
Cryptococcus gattii is an endemic pathogen in the northern 
and northeastern regions of Brazil, but it has rarely been reported 
in the southeastern region, probably because of the cooler and 
drier climate1,2. It has classically been related to lung and/or CNS 
infections among immunocompetent patients. Skin involvement in 
immunocompromised patients, as demonstrated here, is very rare2.
As stated in the introduction to this paper, C. gattii has mostly 
been isolated from decomposing wood in tropical or subtropical 
areas. Trees in urban public squares might also be implicated9. In 
our case, the riverbank forest and the public square could both have 
been the source of the pathogen. The heavy exposure to pigeon feces 
reported by the patient is intriguing, since this has not been described 
as a risk factor for C. gattii infection, although it has been described 
as a factor for C. neoformans infection. On the other hand, this may 
have just been a confounding factor in the clinical history.
This case emphasizes that, although rare, C. gattii may cause 
localized skin infection among immunocompromised patients living 
in the southeastern region of Brazil. It must therefore be borne in 
mind as a potential diagnosis, when clinically feasible.
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